"A targeted antibiotic provides effective and long-lasting relief of Irritable Bowel Syndrome symptoms, according to the results of two multisite Phase III clinical trials designed by Cedars-Sinai researchers. Rifaximin is the first drug treatment for IBS that relieves symptoms while it's being administered and continues to benefit patients after they stop taking the drug."
Saturday, May 8, 2010
Hope for IBS Sufferers
ScienceDaily:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment